Arizona State University/Halberd Corp. Outline Partnership 2nd Stage Goals of $1.4 M Covid-19 Program
Jackson Center, PA, September 17, 2020 – Halberd Corporation (OTC PINK: "HALB") today outlined the specifics of the second stage goals of the $1.4 Million seven-phase research project with Arizona State University. The second stage of the research involves an investigation of a method using dialysis, or a variant of dialysis, to remove the fluorescent antibody-antigen complex, for the rapid identification of a Covid-19 sample. In an earlier press release, we enumerated the initial phase ...
Halberd Corporation Outlines Multi-Phase $1.4 M Covid-19 Program in Partnership With ASU
Jackson Center, PA, September 14, 2020 – Halberd Corporation (OTC PINK: "HALB") today released the specifics of the initial phase of the $1.4 Million seven-phase research project with Arizona State University. The University project for a rapid test to identify Covid-19 infection, from a sample such as saliva, mucus, blood and CSF will be based upon the following two provisional patent applications: Method for Treating and Curing Covid-19 Infection, and Method for the Rapid Identification ...
Halberd Corporation Research on Covid-19 Treatment Development Begins at ASU
Jackson Center, PA, September 8, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced Arizona State University (ASU) commenced its research work for Halberd Corp. The initial phases of ASU’s research focuses on the development of antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications for extracorporeal removal of the virus’ antigens from a patient’s blood. Those antibodies could be multifaceted, including with regard to other viruses. The research ...
MoneyTV Interview With Donald Baillargeon
On MoneyTV with Donald Baillargeon, Halberd Corporation CEO William Hartman explained why they chose Arizona State University as their research partner.
Why Halberd Corporation Selected ASU And Where They Stand Among Other Universities
Jackson Center, PA, September 2, 2020 – Halberd Corporation (OTC PINK: "HALB") today revealed why they selected Arizona State University (ASU) to conduct sponsored research to develop a Covid-19 treatment. ASU is one of the fastest growing research universities in the country and ranks among the top 10 for Department of Health and Human Services funding among all U.S. institutions without a medical school, placing them ahead of Princeton, Georgia Tech and Carnegie Mellon University. ...
Halberd Selects Arizona State University (ASU) to Develop Its Patented Covid-19 Treatment(s)
Jackson Center, PA, August 31, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd’s Covid-19 treatments. The work will focus on developing antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications for extracorporeal removal of the virus’ antigens from a patient’s blood. It will also focus on neutralizing the effects of ...